anmelden
OMX Nordic 40
2.711,69
PKT
-3,84
PKT
-0,14
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.02.21 | Nokia Neutral | Credit Suisse Group | |
| 11.02.21 | A.P. Moeller - Maersk A-S (B) buy | Jefferies & Company Inc. | |
| 11.02.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 11.02.21 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 11.02.21 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 11.02.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 11.02.21 | A.P. Moeller - Maersk A-S (B) overweight | JP Morgan Chase & Co. | |
| 10.02.21 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 10.02.21 | A.P. Moeller - Maersk A-S (B) buy | Jefferies & Company Inc. | |
| 10.02.21 | AstraZeneca buy | Deutsche Bank AG | |
| 10.02.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 10.02.21 | Volvo (B) buy | Jefferies & Company Inc. | |
| 09.02.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 08.02.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 08.02.21 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 08.02.21 | AstraZeneca Neutral | UBS AG | |
| 08.02.21 | ABB (Asea Brown Boveri) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.02.21 | ABB (Asea Brown Boveri) Equal weight | Barclays Capital | |
| 05.02.21 | Nokia Equal weight | Barclays Capital | |
| 05.02.21 | A.P. Moeller - Maersk A-S (B) Outperform | Credit Suisse Group | |
| 05.02.21 | Volvo (B) buy | Deutsche Bank AG | |
| 05.02.21 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 05.02.21 | Nokia buy | Deutsche Bank AG | |
| 05.02.21 | Nokia Neutral | JP Morgan Chase & Co. | |
| 05.02.21 | A.P. Moeller - Maersk A-S (B) buy | Jefferies & Company Inc. | |
| 05.02.21 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 04.02.21 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 04.02.21 | Novo Nordisk overweight | Barclays Capital | |
| 04.02.21 | Volvo (B) Neutral | UBS AG | |
| 04.02.21 | ABB (Asea Brown Boveri) Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.02.21 | Novo Nordisk Neutral | Credit Suisse Group | |
| 04.02.21 | Nokia Neutral | Credit Suisse Group | |
| 04.02.21 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 04.02.21 | ABB (Asea Brown Boveri) Underperform | Jefferies & Company Inc. | |
| 04.02.21 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 04.02.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 04.02.21 | Volvo (B) overweight | JP Morgan Chase & Co. | |
| 04.02.21 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 03.02.21 | Novo Nordisk Outperform | Bernstein Research | |
| 03.02.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. |
